Urinary stone disease refers to the deposition of crystals, most commonly calcium oxalate and calcium phosphate, within the kidneys and urinary system. While urinary stone disease is not classically thought of as a metabolic disorder, a positive association between urinary stone disease and adverse cardiovascular events (e.g., myocardial infarction) has been reported, with vascular calcifications suggested as the pathological link between the two disorders.1